This compound is a deuterated active pharmaceutical ingredient, structurally characterized as a pentadeuteriophenyl-substituted isoquinoline carboxylate with an azabicyclooctane moiety. Its significance lies in its use as a stable isotope-labeled pharmaceutical raw material supplied for research and development applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1401416-00-9
Kenalog
pharmaceutical raw material
(11β,16α)-9-Fluoro-11,17,21-trihydroxy-16-methyl(4,6,6,21,21-²H₅)pregna-1,4-diene-3,20-dione
pharmaceutical raw material
Nicotinic-d4 Acid
pharmaceutical raw material
Agomelatine D6
pharmaceutical raw material
Triptorelin acetate
pharmaceutical raw material
Amoxapine
pharmaceutical raw material
Gentamicin
pharmaceutical raw material
Neomycin
pharmaceutical raw material
[(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-(2,3,4,5,6-pentadeuteriophenyl)-3,4-dihydro-1H-isoquinoline-2-carboxylate
FBOUYBDGKBSUES-GNVVIGMASA-N
[2H]C1=C(C(=C(C(=C1[2H])[2H])[C@H]2C3=CC=CC=C3CCN2C(=O)O[C@H]4CN5CCC4CC5)[2H])[2H]
—